Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.32 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.32 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.32 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.32 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.32 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.32 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10581307 | 0.84 | EPHX2 (0.33) | EPHX2 | |
| SCHEMBL7596987 | 0.75 | EPHX2 (0.36) | EPHX2 | |
| SCHEMBL28330036 | 0.74 | — | — | |
| SCHEMBL21086719 | 0.73 | — | — | |
| SCHEMBL1485707 | 0.72 | — | — | |
| SCHEMBL9640756 | 0.72 | — | — | |
| SCHEMBL14397938 | 0.69 | EPHX2 (0.35) | EPHX2 | |
| SCHEMBL17146854 | 0.69 | EPHX2 (0.38) | RAB9AEPHX2 | |
| SCHEMBL1485960 | 0.69 | LMNA (0.36) | — | |
| SCHEMBL15221247 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0984982-A1 | LH-RH PEPTIDE ANALOGUES, THEIR USES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | LABORATOIRE THERAMEX (MC) | 2000-03-15 | — | — | EP | claimed |
| US-4073687-A | PENICILLINS OR CEPHALOSPORINS | SHIONOGI & CO., LTD. (JA) | 1978-02-14 | — | — | US | claimed |
| EP-3991983-A1 | ORIGINAL PLATE FOR ON-PRESS DEVELOPMENT TYPE LITHOGRAPHIC PRINTING PLATE, METHOD FOR FABRICATING LITHOGRAPHIC PRINTING PLATE, AND LITHOGRAPHIC PRINTING METHOD | FUJIFILM Corporation (JP) | 2022-05-04 | — | — | EP | disclosed |
| EP-3900942-A1 | LITHOGRAPHIC PRINTING PLATE PRECURSOR, METHOD FOR MANUFACTURING LITHOGRAPHIC PRINTING PLATE, AND LITHOGRAPHIC PRINTING METHOD | FUJIFILM Corporation (JP) | 2021-10-27 | — | — | EP | disclosed |
| US-7048907-B2 | Synthesis, compositions and methods for the measurement of the concentration of stable-isotope labeled compounds in life forms and life form excretory products | BIOPHYSICS ASSAY LABORATORY, INC. (US) | 2006-05-23 | — | — | US | disclosed |
| US-20060067881-A1 | Synthesis, compositions and methods for the measurement of the concentration of stable-isotope labeled compounds in life forms and life form excretory products | BIOPHYSICS ASSAY LABORATORY, INC. | 2006-03-30 | — | — | US | disclosed |
| EP-1399170-A2 | CHELATES OF METALS WHICH CAN BE ACTIVATED BY NEUTRONS AND THEIR USE FOR THE MEASUREMENT OF LABELED SPECIMENS | Biophysics Assay Laboratory, Inc. (US) | 2004-03-24 | — | — | EP | disclosed |
| US-20030059368-A1 | Synthesis, compositions and methods for the measurement of the concentration of stable-isotope labeled compounds in life forms and life form excretory products | BIOPAL, INC. | 2003-03-27 | — | — | US | disclosed |
| WO-2002062397-A2 | CHELATES OF METALS WHICH CAN BE ACTIVATED BY NEUTRONS AND THEIR USE FOR THE MEASUREMENT OF LABELED SPECIMENS | BIOPHYSICS ASSAY LABORATORY, INC. (US) | 2002-08-15 | — | — | WO | disclosed |
| EP-1117420-A1 | PHARMACEUTICAL COMPOSITIONS BASED ON ALPHA-CYCLODEXTRIN FOR THE ORAL ADMINISTRATION OF LH-RH ANALOGUES | LABORATOIRE THERAMEX S.A. (MC) | 2001-07-25 | — | — | EP | disclosed |
| WO-2000018423-A1 | PHARMACEUTICAL COMPOSITIONS BASED ON ALPHA-CYCLODEXTRIN FOR THE ORAL ADMINISTRATION OF LH-RH ANALOGUES | LABORATOIRE THERAMEX (MC) | 2000-04-06 | — | — | WO | disclosed |
| EP-0984982-A1 | LH-RH PEPTIDE ANALOGUES, THEIR USES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | LABORATOIRE THERAMEX (MC) | 2000-03-15 | — | — | EP | disclosed |
| WO-1998055505-A1 | LH-RH PEPTIDE ANALOGUES, THEIR USES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | LABORATOIRE THERAMEX (MC) | 1998-12-10 | — | — | WO | disclosed |
| US-4073687-A | PENICILLINS OR CEPHALOSPORINS | SHIONOGI & CO., LTD. (JA) | 1978-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060067881-A1 | Synthesis, compositions and methods for the measurement of the concentration of stable-isotope labeled compounds in life forms and life form excretory products | ATP6V1B1, REN, GLS | TP53 3580/4885RAB9A 562/4885GRIN2D 4775/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.